|Bid||0.6400 x 1200|
|Ask||0.6770 x 3200|
|Day's range||0.6300 - 0.7313|
|52-week range||0.4600 - 3.8900|
|Beta (5Y monthly)||2.18|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Infinity (INFI) delivered earnings and revenue surprises of 0% and 65.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Infinity Pharmaceuticals, Inc. ( NASDAQ:INFI ) shareholders should be happy to see the share price up 24% in the last...